Avicenna Alliance to develop Public Private Partnership on in silico medicine

The Avicenna Alliance has been given the green light by the European Commission to pursue the creation of a Public Private Partnership (PPP) on in silico medicine.
Promoting in silico medicine

The Avicenna Alliance is currently engaged in outreach with a multitude of organisations with an interest in in silico technologies to pursue the creation of a PPP. The development of a PPP is the primary activity of the Avicenna Alliance for its 1st year and aims to create new funding streams for in silico projects across Europe.

The Alliance will be in continuous contact with the European Commission to ensure the maximum value of this PPP.

For more information on the Avicenna Alliance click here. 


Gallery:

Promoting in silico medicine
Date: 26/02/2015 | Tag: | News: 357 of 1573
All news

News

  • 03/04/2024

    VPHi Best Poster Award 2024

    • All VPHi student members bringing a poster to the VPH2024 Conference will be automatically considered for the VPHi Best Poster Award that consists in a Certificate and a 350€ money prize. -Read more-
  • 03/04/2024

    VPHi Travel Award for the VPH Conference 2024

    • The VPHi Institute will give Travel Awards to student members that are applying to participate at the VPH2024 Conference in Stuttgart -Read more-
  • 03/04/2024

    Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation

    • The National Science Foundation (NSF) published a call for funding (n: 24-561) dedicated to Digital Twins. -Read more-
  • 02/04/2024

    Event at the European Parliament on in silico medicine and in silico oncology

    • On 21 February 2024 a European Parliament (EP) info event on in silico medicine and in silico oncology took place in the Altiero Spinelli building in Brussels. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO